Keap1-resistant ΔN-Nrf2 isoform does not translocate to the nucleus upon electrophilic stress
Mikac, S.; Dziadosz, A.; Padariya, M.; Kalathiya, U.; Fahraeus, R.; Marek-Trzonkowska, N.; Chrusciel, E.; Urban-Wojciuk, Z.; Papak, I.; Arcimowicz, Łukasz; Marjanski, T.; Rzyman, W.; Sznarkowska, A.
Show abstract
The Nrf2 pathway is an essential defense pathway in a cell. It responds to oxidative and electrophilic stress via derepression of Nrf2 from Keap1-Cul3-mediated degradation, accumulation of Nrf2 in the nucleus and transcriptional activation of a number of detoxifying and cell protective Nrf2 target genes. Here we report that normal and cancer cells also express the N-terminally truncated Nrf2 isoform ({Delta}N-Nrf2), which originates from an alternative promoter. Co-immunoprecipitation together with molecular dynamics simulation showed that the binding between {Delta}N-Nrf2 and Keap1 is impaired, resulting in the much higher stability of this form. {Delta}N-Nrf2 is retained in the cytoplasm in response to electrophilic stress, indicating that it does not regulate transcription under the same stress stimuli as the full-length Nrf2. Altogether this data suggests that Nrf2 has other functions in cells than transcriptional activation of genes, which most probably rely on the protein-protein interactions in the cytoplasm. The regulation between these functions takes place on the level of transcription. Significance StatementThis work signifies the importance of alternative transcription in assigning the function to the produced protein. Nrf2 transcripts produced from the second promoter of the Nrf2 gene give rise to the N-terminally truncated Nrf2 form ({Delta}N-Nrf2), which is retained in the cytoplasm upon stress, thus it has a different role in cells than transcriptional regulation. {Delta}N-Nrf2 is resistant to the Keap1-Cul3 degradation pathway and is highly expressed in all tested cell types. This work points to the new, cytoplasmic role of Nrf2 in cells, determined at the level of transcription.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells 95%
- Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks 94%
- Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs 93%
Similar papers in this journal
- Olaparib and Enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling 93%
- SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC 93%
- Maternal RND3/RhoE deficiency impairs placental mitochondrial function in preeclampsia by modulating PPARγ-UCP2 cascade 92%
Similar papers in this journal
- Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species (ROS) in human hepatoma cells, which is alleviated by 2-bromopalmitate 94%
- Metabolomic profiling reveals grade-specific niacinamide accumulation and its therapeutic Potential via SIRT1-CD38-EMT axis modulation in cervical cancer progression 93%
- Activation of the membrane-bound Nrf1 transcription factor by USP19, a ubiquitinspecific protease C-terminally tail-anchored in the endoplasmic reticulum 92%
Similar papers in this journal
Similar papers in this journal
- Nrf1 is not a direct target gene of SREBP1, albeit both are integrated into the rapamycin-responsive regulatory network in human hepatoma cells 94%
- Altering mammalian transcription networking with ADAADi: An inhibitor of ATP-dependent chromatin remodeling 94%
- The nuclear receptor NR4A1 is regulated by SUMO modification to induce autophagic cell death 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.